Danaher Co. (NYSE:DHR) Shares Sold by Neville Rodie & Shaw Inc.

Neville Rodie & Shaw Inc. reduced its stake in Danaher Co. (NYSE:DHR - Free Report) by 6.7% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 80,730 shares of the conglomerate's stock after selling 5,791 shares during the quarter. Danaher accounts for 1.3% of Neville Rodie & Shaw Inc.'s investment portfolio, making the stock its 21st largest position. Neville Rodie & Shaw Inc.'s holdings in Danaher were worth $16,549,000 as of its most recent filing with the SEC.

Several other large investors have also recently made changes to their positions in DHR. Heck Capital Advisors LLC purchased a new position in shares of Danaher in the fourth quarter valued at approximately $27,000. Golden State Wealth Management LLC purchased a new position in shares of Danaher in the fourth quarter valued at approximately $31,000. Strategic Financial Concepts LLC purchased a new position in shares of Danaher in the fourth quarter valued at approximately $31,000. Pineridge Advisors LLC boosted its stake in shares of Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock valued at $34,000 after purchasing an additional 57 shares during the period. Finally, Kentucky Trust Co purchased a new position in shares of Danaher in the fourth quarter valued at approximately $34,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Performance

NYSE:DHR traded down $0.33 during trading hours on Monday, reaching $189.58. 1,141,095 shares of the company's stock were exchanged, compared to its average volume of 3,470,720. The firm has a market capitalization of $135.67 billion, a price-to-earnings ratio of 35.89, a P/E/G ratio of 2.66 and a beta of 0.80. The company has a 50-day moving average of $192.72 and a 200 day moving average of $213.41. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. Danaher Co. has a 1-year low of $171.00 and a 1-year high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. The firm had revenue of $5.74 billion during the quarter, compared to analysts' expectations of $5.58 billion. Danaher had a net margin of 16.33% and a return on equity of 10.82%. Research analysts anticipate that Danaher Co. will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.68%. Danaher's dividend payout ratio is currently 24.85%.

Analyst Ratings Changes

Several research firms have recently commented on DHR. Robert W. Baird lowered their price objective on shares of Danaher from $231.00 to $225.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. The Goldman Sachs Group decreased their price target on shares of Danaher from $260.00 to $240.00 and set a "neutral" rating for the company in a research note on Wednesday, April 23rd. Stifel Nicolaus raised shares of Danaher from a "hold" rating to a "buy" rating and set a $260.00 price objective on the stock in a research report on Friday, March 14th. Royal Bank of Canada reissued an "outperform" rating and issued a $250.00 price objective on shares of Danaher in a research report on Wednesday, April 23rd. Finally, Guggenheim reissued a "buy" rating and issued a $250.00 price objective on shares of Danaher in a research report on Wednesday, April 23rd. Four analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. Based on data from MarketBeat, Danaher currently has an average rating of "Moderate Buy" and an average target price of $263.24.

Insider Buying and Selling at Danaher

In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of the business's stock in a transaction on Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the transaction, the chairman now directly owns 3,105,808 shares of the company's stock, valued at approximately $611,036,665.92. The trade was a 28.70% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Christopher Paul Riley sold 15,805 shares of the business's stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the transaction, the executive vice president now directly owns 15,179 shares in the company, valued at $3,005,442. This represents a 51.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.10% of the stock is currently owned by corporate insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.